Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects

Clinical trial NCT06195319 · COMPLETED

Trial details

NCT number: NCT06195319
Sponsor: Cassava Sciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Absorption Metabolism Excretion

Start date: 2024-02-07
Primary completion: 2024-03-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.